DEA Expands Telemedicine Prescribing Authority for Buprenorphine

Summary

The Drug Enforcement Administration (DEA) is amending its regulations to allow individual practitioners to prescribe schedule III-V narcotic drugs via telemedicine encounters, including audio-only calls, for continuous medical treatment and withdrawal management treatment.